Showing results (41-50 of 50) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 50 results.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|April 17, 2012
[A case of lung metastases of carcinoma of the ampulla of vater effectively treated with S-1]Hiroki Hashida, Yoshikage Inoue, Kengo Hattori, et al.
European Journal of Immunology|February 26, 2013
Overcoming regulatory T-cell suppression by a lyophilized preparation of Streptococcus pyogenesMichiko Hirayama, Hiroyoshi Nishikawa, Yasuhiro Nagata, et al.
International Journal of Clinical Oncology|August 28, 2021
Randomized phase II study of CPT-11 versus PTX versus each combination chemotherapy with S-1 for advanced gastric cancer that is refractory to S-1 or S-1 plus CDDP: OGSG0701Tomono Kawase, Hiroshi Imamura, Masahiro Goto, et al.
European Journal of Cancer (Oxford, England : 1990)|July 26, 2021
Randomized phase II study of docetaxel versus paclitaxel in patients with esophageal squamous cell carcinoma refractory to fluoropyrimidine- and platinum-based chemotherapy: OGSG1201Sachiko Yamamoto, Hisato Kawakami, Takayuki Kii, et al.
Vaccine|September 19, 2009
Antibody responses against NY-ESO-1 and HER2 antigens in patients vaccinated with combinations of cholesteryl pullulan (CHP)-NY-ESO-1 and CHP-HER2 with OK-432Masatoshi Aoki, Shugo Ueda, Hiroyoshi Nishikawa, et al.
Journal of Translational Medicine|October 8, 2013
Dose-dependent effects of NY-ESO-1 protein vaccine complexed with cholesteryl pullulan (CHP-NY-ESO-1) on immune responses and survival benefits of esophageal cancer patientsShinichi Kageyama, Hisashi Wada, Kei Muro, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 10, 2015
Adoptive Transfer of MAGE-A4 T-cell Receptor Gene-Transduced Lymphocytes in Patients with Recurrent Esophageal CancerShinichi Kageyama, Hiroaki Ikeda, Yoshihiro Miyahara, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|March 17, 2026
A phase II study of neoadjuvant chemotherapy with docetaxel, cisplatin, and S-1 followed by gastrectomy for type 4 or large type 3 gastric cancer (OGSG 1402)Ryo Tanaka, Sang-Woong Lee, Kazumasa Fujitani, et al.
Annals of Surgical Oncology|November 11, 2023
Phase II Study of Intraperitoneal Administration of Paclitaxel Combined with S-1 and Cisplatin for Gastric Cancer with Peritoneal MetastasisDaisuke Kobayashi, Yasuhiro Kodera, Ryoji Fukushima, et al.
Cancer Immunology, Immunotherapy : CII|April 16, 2022
Prognostic significance of NY-ESO-1 antigen and PIGR expression in esophageal tumors of CHP-NY-ESO-1-vaccinated patients as adjuvant therapyYasuhiro Nagata, Shinichi Kageyama, Takeshi Ishikawa, et al.
Pageof 5